Bristol Myers Squibb (CGT Mfg) vs Pharmaron: CDMO Comparison

How does Bristol Myers Squibb (CGT Mfg) compare to Pharmaron?

As of Nov 2026, Bristol Myers Squibb (CGT Mfg): 8 FDA inspections (including 4 NAI, 4 VAI and 0 OAI), 2 EMA/MHRA GMP certificates. Signal Score 87. Pharmaron: 5 FDA inspections (including 4 NAI, 1 VAI and 0 OAI), 1 EMA/MHRA GMP certificate. Signal Score 86.9. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.

Side-by-side comparison of Bristol Myers Squibb (CGT Mfg) and Pharmaron on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Bothell, WA · Warren, NJ
Signal Score
87/100
Quality (FDA + GMP)
97/100
FDA inspections
8
— NAI / VAI / OAI
4 / 4 / 0
FDA warning letters
0
EMA GMP certificates (active)
1
MHRA GMP certificates (compliant)
1
Clinical programs (matched)
586
Capacity
—
Modalities
CAR-T, Cell Therapy
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score
87/100
Quality (FDA + GMP)
100/100
FDA inspections
5
— NAI / VAI / OAI
4 / 1 / 0
FDA warning letters
0
EMA GMP certificates (active)
0
MHRA GMP certificates (compliant)
1
Clinical programs (matched)
0
Capacity
Available
Modalities
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars

Key differences

  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • Bristol Myers Squibb (CGT Mfg) holds 1 active EMA GMP certificates; Pharmaron does not appear in EudraGMDP.
  • Bristol Myers Squibb (CGT Mfg) appears as a manufacturing partner on more matched clinical programs (586 vs 0) — a broader sponsor book.

Across the cross-modality scorecard, Bristol Myers Squibb (CGT Mfg) carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.

Frequently asked: Bristol Myers Squibb (CGT Mfg) vs Pharmaron

How does Bristol Myers Squibb (CGT Mfg) compare to Pharmaron?

On CDMO Signal's composite Signal Score, Bristol Myers Squibb (CGT Mfg) is 87/100 and Pharmaron is 87/100; Bristol Myers Squibb (CGT Mfg) has 8 FDA inspections on record vs 5 for Pharmaron; European coverage is 2 active EMA+MHRA certificates for Bristol Myers Squibb (CGT Mfg) vs 1 for Pharmaron. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.

Which has the stronger FDA inspection record, Bristol Myers Squibb (CGT Mfg) or Pharmaron?

Both Bristol Myers Squibb (CGT Mfg) and Pharmaron maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Bristol Myers Squibb (CGT Mfg) has 8 FDA inspections on record; Pharmaron has 5.

How do Bristol Myers Squibb (CGT Mfg) and Pharmaron compare on European GMP coverage?

Bristol Myers Squibb (CGT Mfg) holds 1 active EMA GMP certificate and 1 MHRA / UK certificate. Pharmaron holds 0 active EMA GMP certificates and 1 MHRA / UK certificate. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is more active in clinical-stage manufacturing — Bristol Myers Squibb (CGT Mfg) or Pharmaron?

Bristol Myers Squibb (CGT Mfg) is matched to 586 ClinicalTrials.gov records as a manufacturing partner; Pharmaron is matched to 0. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.

What does the Signal Score gap mean in practice?

Bristol Myers Squibb (CGT Mfg) carries a Signal Score of 87/100 and Pharmaron carries 87/100 — essentially tied for Bristol Myers Squibb (CGT Mfg). The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating Bristol Myers Squibb (CGT Mfg) and Pharmaron for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.